Member Info for Asleep

Hoping for at least a £50m upfront payment with £3-4m milestone payments. An Eli share stake in Hemo would also be welcomed.

If there is ever a takeover approach I bet there would be a lot of interest with the high profile companies Hemo are linked with. Hoping next week is a steady increase to between 10-12p, it would be great if we had a postive update before any Eli Lilly announcement. A move towards 20p before the announcement would be great. If we had to wait another 3 months I would be disappointed - why not have had a 6 month extension in the first place. I think it would be embarrassing for both companies, however I could wait until Xmas no problem.

Just when cases are starting to pick up it would be timely for Hemo to provide a Covid update to propel the share price forward a few pence. Fully loaded here, no more spare cash to add - just waiting.

Just to clarify. The original agreement was from May 14th 2018 for 2 years. Adding the 3 MTH extension gives August 14th. I am I right in saying therefore the agreement has ended, and we should have news next week of what is happening?

always a risk here, however Vlad has built up a positive relationship with Lilly as mentioned in recent video.

Small pieces of positive news recently are helping to push up the share price slowly, which Vlad will want before the big news arrives to propel the share price into the stratosphere.

So much uncertainty, but stimulus packages will keep gold high for now. China tensions and an uncertain US election. I am not selling in August, may consider selling a few at £2.50.

It looks like my prediction of £10 per share is coming to fruition. With continued Covid issues keeping people in doors etc Gamesys should be benefiting. Predict £10 by August 15th. Good Luck me as I am the only one who posts on here at the moment. It's great no bickering etc. And I can say whatever I like. All good, now show me the money Gamesys!

I think there will be a three month extension - just my gut instinct given Eli Lilli' involvement in Covid work which brings it into October.

Tils RNS doesn't look grim in terms of share price and its only a submission.

Proposal to spend 25 billion dollars on testing Guardian article. Gdr need that approval.

Some have said about 'ducks lining up' and I do believe there is merit in this. A few things which I initially had reservations about have been resolved. Firstly, we had a share placing to help strengthen the balance sheet/cash resources at 7p. Secondly, we had the Financial Dir purchasing shares for approx £25,000 at 6.78p or therebouts, we had the naming of the 'global co' as Eli Lilly, the Q&A which was never going to reveal price senstive info, and the granting and take up of options by two directors for 4,400,000 shares at 7p - announced at same time as Eli Lilly reveal. I therefore believe that this is a good investment and I am willing to wait until there are further announcements but I am in no rush because these things take time. Therefore the upside potential is massive and downside risk at these prices fairly low. As investments go I am fairly risk averse with my other company being Centamin Egypt - CEY - Gold, but I have accepted that Hemo is worth the risk of having some investment funds.

What everybody wants in the first instance is a licencing deal and part ownership investment by Eli Lilly. This would propel the share into space. Otherwise it could be a Covid update or Mice contract or any other business arrangement e.g. with J&J or Orogenesis. We must have financials which will add significant impact to the RNS and share price. Don't expect a takeover, not yet anyway, share price too low. Covid update equals upto 30p. Followed by licencing deal £2 plus, followed by takeover £3 plus.

It is very clear in the last trading update that the regulatory bodies have an increased workload and therefore time scales are not possible to make. There is no conspiracy theory or anything else. Patience required that is all.

Yes agreed, cost minimisation coupled with more effective marketing to grow sales to improve profit margins and in particular cash flow. Looks to me like a turnaround strategy with the added bonus of greater website sales and online growth. Nothing not to like, all good.

The detailed article link below provides an excellent insight into what Hemogenyx have been doing. It outlines all their work upto March 2018 and I believe the developments so far provides an excellent indication of the future potential of the company in terms of an investment opportunity. It shows the pipeline of opportunities all of which demonstrate the commitment, scientific knowledge and drive of its founder.

http://www.alignresearch.co.uk/wp-content/uploads/2018/02/Hemogenyx_Align-Research_1st_March_2018.pdf

What are we expecting? In the Lakes all day and night.

I' m sorry but if Stem is worth over £16 per share as you predict why is Tils currently sitting at £1.80? Maybe you can enlighten me.

Tils has been skirting between £1.65 and £1.70 all morning. Needs a leg up.

Another 10,000 shares at these prices with what is to come its a bargain.